Clinical Trials Sponsored by AGECURVE LIMITED

Total 2851 results

Kazia Therapeutics Limited

Recruiting

Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours

Solid Tumor, Adult

France
Pacific Edge Limited

Recruiting

CxBladder Surveillance of Intermediate and High-Risk Bladder Cancer Patients

Urothelial Bladder Cancer

United States
Neuren Pharmaceuticals Limited

Recruiting

An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome (AS-001)

Angelman Syndrome

Australia
AMO Pharma Limited

Recruiting

Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy (REACH CDM X)

Congenital Myotonic Dystrophy

United States, Canada, Australia, New Zealand
Proveca Pharma Limited

Recruiting

Double-blind, Placebo-controlled, Randomized Clinical Trial Comparing the Efficacy and Safety of Sialanar Plus orAl rehabiLitation Against Placebo Plus Oral Rehabilitation for chIldren and Adolescents With seVere Sialorrhoea and Neurodisabilties, (SALIVA)

Neurodevelopmental Disorders | Sialorrhea

France
Lee's Pharmaceutical Limited

Recruiting

Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma

Local Progression or Metastatic Melanoma With Failed First-line Treatment

China
Lee's Pharmaceutical Limited

Not yet recruiting

A Study of Gimatecan (ST1481) in Small Cell Lung Cancer

Small Cell Lung Cancer

China
OncoSil Medical Limited

Recruiting

OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry. (OSPREY)

Neoplasms | Neoplasms by Site | Endocrine System Diseases | Pancreatic Diseases | Digestive System Neoplasm | Digestive System Disease | Pancreatic Neoplasm | Endocrine Gland Neoplasm

Spain, United Kingdom
Lee's Pharmaceutical Limited

Not yet recruiting

Study of ZKAB001 for Maintenance Therapy in Patients With High-grade Osteosarcoma After Adjuvant Chemotherapy

High-grade Osteosarcoma
Lee's Pharmaceutical Limited

Recruiting

Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer

Extensive Stage Small Cell Lung Cancer

China
LumiraDx UK Limited

Recruiting

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites (INSPIRE)

Influenza, Human | Respiratory Syncytial Virus Infections

United States
RedHill Biopharma Limited

Not yet recruiting

Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years

Traveler's Diarrhea
Future Genetics Limited

Recruiting

EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality

Depression | Cardiovascular Diseases | Heart Failure | Epilepsy | Hypertension | Obesity | Diabetes Mellitus | Cancer | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Rheumatoid Arthritis | Peripheral Arterial Disease | Atrial Fibrillation | Asthma | Dementia | Blood Pressure | Coronary Heart Disease | Mental... and other conditions

United Kingdom
Lee's Pharmaceutical Limited

Recruiting

A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma

Osteosarcoma

China
Lee's Pharmaceutical Limited

Completed

Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With BTcP

Breakthrough Cancer Pain

China
Cynata Therapeutics Limited

Active, not recruiting

Safety, Tolerability and Efficacy of CYP-006TK in Adults With Diabetic Foot Ulcers

Diabetic Foot Ulcer | Cutaneous Ulcer

Australia
Kymab Limited
Sanofi

Completed

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study (STREAM-AD)

Eczema | Atopic Dermatitis

United States, Australia, Bulgaria, Canada, Czechia, Germany, Hungary, Japan, Poland, Spain, Taiwan, United Kingdom
Kymab Limited
Sanofi

Active, not recruiting

Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer

Melanoma | Renal Cell Carcinoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Advanced Cancer

United States, Hungary, Italy, Poland, Taiwan, United Kingdom
Thirty Respiratory Limited

Terminated

COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2 (CORVIS)

Bronchiectasis | COPD

United Kingdom
Pacific Edge Limited

Active, not recruiting

STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA

Urothelial Carcinoma | Hematuria

United States, Canada
Beckley Psytech Limited

Completed

Single Ascending Dose Study With BPL-003 in Healthy Subjects

Pharmacokinetics in Healthy Adults

United Kingdom
Kazia Therapeutics Limited

Completed

Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

Glioblastoma, Adult

United States
ResApp Health Limited

Completed

A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Adolescent and Adult Patients in an Emergency Department

Pneumonia | Asthma Exacerbation | COPD Exacerbation | Lower Respiratory Disease

United Kingdom
Aerogen Pharma Limited

Active, not recruiting

A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact

Respiratory Distress Syndrome in Premature Infant

United States, Canada
Brii Biosciences Limited

Completed

A Study of BRII-297 in Healthy Adult Subjects

Postpartum Depression

Australia
LumiraDx UK Limited

Completed

A Performance Evaluation of the Lumiradx Point of Care HbA1c Device (PHADE)

Diabetes

United Kingdom
LumiraDx UK Limited

Suspended

COVID-19: A POC Test Under Research & Evaluation (CAPTURE)

COVID-19

United Kingdom
Everstar Therapeutics Limited

Active, not recruiting

A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis

Moderately to Severely Active Ulcerative Colitis

China
LumiraDx UK Limited

Completed

A Performance Evaluation of the LumiraDx Point of Care CRP Assay (REACT)

Infections | Inflammation | Tissue Injury

United Kingdom
Pfizer
BioShin Limited

Completed

Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine

Acute Migraine

Korea, Republic of, China
Mina Alpha Limited

Active, not recruiting

First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer (OUTREACH)

Hepatocellular Carcinoma | Liver Cancer

Taiwan, Singapore, United Kingdom
Zoe Global Limited

Active, not recruiting

ZOE's Ferment Experiment (ZHS-FE)

Mood | Hunger | Energy

United Kingdom
RedHill Biopharma Limited

Completed

Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia

COVID-19 | Lung Infection

United States, Brazil, Colombia, Israel, Italy, Mexico, Peru, Poland, Russian Federation, United Kingdom
Clinuvel Pharmaceuticals Limited

Completed

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)

Vitiligo
Mundipharma Research Limited

Completed

Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors

Soft Tissue Sarcoma | Ovarian Cancer | Endometrial Cancer | Small-cell Lung Cancer | Triple-negative Breast Cancer

United States, Canada
Neuren Pharmaceuticals Limited

Active, not recruiting

An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001) (PMS-001)

Phelan-McDermid Syndrome

United States
Aya Technologies Limited

Completed

Efficacy and Safety of the Alena App as a Treatment for Social Anxiety Disorder

Social Anxiety | Social Anxiety Disorder | Social Anxiety Disorder (Social Phobia)

United Kingdom
Citrine Medicine Limited

Completed

A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA

Excessive Daytime Sleepiness

China
Evolution Optiks Limited

Completed

LFR-260 vs Traditional Phoropter in Visual Acuity Testing

Astigmatism | Visual Acuity | Anisometropia

United States
Clinuvel Pharmaceuticals Limited

Completed

A Proof of Concept Study to Evaluate the Safety of Afamelanotide in Patients With Acute Arterial Ischaemic Stroke (AIS)

Arterial Ischemic Stroke

Australia
RedHill Biopharma Limited

Completed

A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma

Cholangiocarcinoma | Cholangiocarcinoma Non-resectable | Cholangiocarcinoma, Perihilar | Cholangiocarcinoma, Extrahepatic | Cholangiocarcinoma, Intrahepatic

United States
Prestige Biopharma Limited

Completed

A Study to Demonstrate the Equivalent Pharmacokinetic Properties of a Single Intravenous Dose of HD201 and EU-Herceptin® and US-Herceptin® in Healthy Male Subjects (TROIKA-1)

Healthy Volunteers

Australia
Torrent Pharmaceuticals Limited

Withdrawn

Efficacy and Safety of TRC041266 in Patients With Heart Failure, LVEF ≥40%, Diastolic Dysfunction and Type 2 Diabetes Mellitus

Chronic Stable Heart Failure
LaNova Medicines Limited

Terminated

Study of LM-102 in Subjects in Advanced Tumors

Advanced Solid Tumors

United States
Globe Biotech Limited

Completed

A Randomized, Double-blinded, Active Controlled Crossover Clinical Trial to Investigate PK, PD and Safety of GBPD002

Natural Blood and Blood Product Toxicity

Bangladesh
TenNor Therapeutics Limited

Completed

Absorption, Metabolism, and Excretion Study of [14C]-TNP-2092

Healthy

United States
LumiraDx UK Limited

Active, not recruiting

A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay (EMBOL1)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United Kingdom, Germany
GammaDelta Therapeutics Limited

Terminated

Study of GDX012 in Patients With MRD Positive AML

Acute Myeloid Leukemia

United States
Health Clinics Limited

Withdrawn

Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer (METRICS)

Cancer | Overall Survival

United Kingdom
Lee's Pharmaceutical Limited

Active, not recruiting

A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.

Esophageal Cancer

China

Clinical Trials Sponsored by AGECURVE LIMITED

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations